Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer
Author:
Funder
Cancer Research UK
National Institutes of Health
Publisher
Elsevier BV
Subject
Cancer Research,Cell Biology,Oncology
Reference73 articles.
1. A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells;Anders;Cancer Cell,2011
2. Alpelisib for PIK3CA-mutated, hormone receptor–positive advanced breast cancer;André;N. Engl. J. Med.,2019
3. POSEIDON trial phase 1b results: safety, efficacy and circulating tumor DNA response of the beta isoform-sparing PI3K inhibitor Taselisib (GDC-0032) combined with tamoxifen in hormone receptor positive metastatic breast cancer patients;Baird;Clin. Cancer Res.,2019
4. Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression;Barger;Oncotarget,2015
5. PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer;Bosch;Sci. Transl. Med.,2015
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. FOXM1 transcriptional regulation;Biology of the Cell;2024-07-04
2. Mechanism of miR-126 Loaded in Albumin Nanoparticles for Reversing the Multidrug Resistance in Breast Carcinoma Cells;Journal of Biomedical Nanotechnology;2024-06-01
3. Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer—a call for enhanced surveillance strategies;npj Precision Oncology;2024-03-29
4. A novel signature integrated endoplasmic reticulum stress and apoptosis related genes to predict prognosis for breast cancer;Heliyon;2024-03
5. Imaging cancer metabolism using magnetic resonance;npj Imaging;2024-01-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3